research Temperature-Dependent Phase Transition Microemulsions for Enhanced Transdermal Delivery of Finasteride and Silodosin
Menthol-based microemulsions improve skin delivery of finasteride and silodosin.
Search
forLearn
0 / 0 results — no results
Research
5 / 37 results research Risk Assessment of the Top 60 Drugs for Drug-Related Sexual Dysfunction: A Disproportionate Analysis from the Food and Drug Administration Adverse Event Reporting System
Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.
research Sexual Dysfunction Related to Drugs: A Critical Review. Part V: Alpha-Blocker and 5-ARI Drugs
α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.
research Most Recent Findings of Curative Drugs for Lower Urinary Tract Symptoms in Clinical Practice
Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.
research New Insight of PSA Reduction During Finasteride Therapy
Finasteride reduces PSA levels by around 40-50% in BPH patients.
Community Join
0 / 0 results — no results